X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6848) 6848
life sciences & biomedicine (6257) 6257
humans (5548) 5548
animals (3414) 3414
signal transduction (2403) 2403
janus kinase 2 - genetics (2380) 2380
male (2124) 2124
female (2099) 2099
mice (1983) 1983
janus kinase 2 (1883) 1883
mutation (1880) 1880
hematology (1811) 1811
oncology (1701) 1701
phosphorylation (1422) 1422
janus kinase 2 - metabolism (1368) 1368
cell biology (1358) 1358
middle aged (1227) 1227
kinases (1170) 1170
biochemistry & molecular biology (1152) 1152
gene expression (1068) 1068
adult (1048) 1048
janus kinase (1048) 1048
aged (1007) 1007
janus kinases - metabolism (987) 987
signal transduction - drug effects (985) 985
genetic aspects (983) 983
proteins (960) 960
stat3 transcription factor - metabolism (953) 953
protein-tyrosine kinases - metabolism (897) 897
cell line, tumor (884) 884
research (879) 879
cytokines (877) 877
immunology (793) 793
abridged index medicus (788) 788
apoptosis (776) 776
cell line (757) 757
myeloproliferative disorders - genetics (723) 723
cells, cultured (714) 714
analysis (691) 691
stat transcription factors - metabolism (663) 663
tumors (659) 659
research article (620) 620
cancer (607) 607
science & technology - other topics (592) 592
multidisciplinary sciences (587) 587
health aspects (575) 575
janus kinase 2 - antagonists & inhibitors (568) 568
dna-binding proteins - metabolism (552) 552
stat3 protein (550) 550
cell proliferation (548) 548
aged, 80 and over (540) 540
hemic and lymphatic diseases (534) 534
trans-activators - metabolism (533) 533
janus kinase 1 (527) 527
jak2 (511) 511
signal transduction - physiology (507) 507
leukemia (499) 499
medicine (497) 497
rats (496) 496
inflammation (493) 493
polycythemia vera - genetics (478) 478
proto-oncogene proteins (468) 468
transcription (465) 465
genes (461) 461
medicine, research & experimental (454) 454
research & experimental medicine (451) 451
signaling (446) 446
stat3 transcription factor - genetics (441) 441
rodents (440) 440
thrombocythemia, essential - genetics (430) 430
care and treatment (422) 422
mice, inbred c57bl (420) 420
janus kinase 1 - metabolism (416) 416
physiological aspects (413) 413
risk factors (410) 410
stem cells (408) 408
protein-tyrosine kinases - genetics (402) 402
gene expression regulation (399) 399
transfection (399) 399
science (396) 396
primary myelofibrosis - genetics (388) 388
janus kinases - genetics (384) 384
apoptosis - drug effects (381) 381
cell proliferation - drug effects (380) 380
molecular sequence data (370) 370
protein kinase inhibitors - pharmacology (370) 370
genetics & heredity (359) 359
young adult (349) 349
signal transduction - genetics (348) 348
myelofibrosis (344) 344
prognosis (344) 344
transcription factors (344) 344
mice, knockout (341) 341
phosphorylation - drug effects (341) 341
polycythemia vera (341) 341
polymerase chain reaction (336) 336
patients (334) 334
adolescent (333) 333
blotting, western (331) 331
stat5 transcription factor - metabolism (331) 331
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7823) 7823
Chinese (59) 59
Japanese (22) 22
French (14) 14
Portuguese (13) 13
German (8) 8
Italian (3) 3
Spanish (2) 2
Croatian (1) 1
Polish (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biochemical journal, ISSN 1470-8728, 05/2009, Volume 420, Issue 3, pp. 345 - 361
RTKs (receptor tyrosine kinases) play important roles in cellular proliferation and differentiation... 
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | Index Medicus | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | neuroblastoma | extracellular-signal-regulated kinase (ERK) | pleiotrophin | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | inflammatory myofibroblastic tumour (IMT) | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | midkine | CLTC, clathrin heavy chain | anaplastic large cell lymphoma (ALCL) | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | non-small cell lung cancer (NSLCL) | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | anaplastic lymphoma kinase (ALK) | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article
Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 17, pp. 3510 - 3518
CRLF2 rearrangements, JAK1/2 point mutations, and JAK2 fusion genes have been identified in Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia... 
Life Sciences & Biomedicine | Hematology | Science & Technology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Immunoglobulins - genetics | Molecular Targeted Therapy | Immunoglobulins - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Janus Kinase 1 - metabolism | STAT5 Transcription Factor - genetics | STAT5 Transcription Factor - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | TOR Serine-Threonine Kinases - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Receptors, Cytokine - metabolism | Drug Evaluation, Preclinical | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Pyrazoles - pharmacology | Acute Disease | Janus Kinase 2 - genetics | Survival Rate | Signal Transduction - genetics | Janus Kinase 1 - antagonists & inhibitors | Sirolimus - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2016, Volume 375, Issue 9, pp. 819 - 829
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 04/2016, Volume 126, Issue 6, pp. 2064 - 2076
Journal Article
Redox biology, ISSN 2213-2317, 07/2019, Volume 25, pp. 101124 - 101124
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 05/2009, Volume 106, Issue 23, pp. 9414 - 9418
Journal Article